Comparison
13q Partial Monosomy Syndrome C0265451 vs 1p35 2 Microdeletion Syndrome
Clinical comparison between 13q Partial Monosomy Syndrome and 1p35 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
13q Partial Monosomy Syndrome C0265451
A rare genetic condition involving deletion of material from chromosome 13. It can lead to developmental delays, growth concerns, and various physical features. Treatment involves supportive care addressing each individual's specific challenges.
1p35 2 Microdeletion Syndrome
6 comparison axes
Onset
13q Partial Monosomy Syndrome C0265451
0-null
1p35 2 Microdeletion Syndrome
0-null
Onset patterns differ
Severity
13q Partial Monosomy Syndrome C0265451
severe
1p35 2 Microdeletion Syndrome
severe
Different severity levels
Chronic
13q Partial Monosomy Syndrome C0265451
Chronic
1p35 2 Microdeletion Syndrome
Chronic
Differing course
Communicable
13q Partial Monosomy Syndrome C0265451
No
1p35 2 Microdeletion Syndrome
No
Different transmission
Body System
13q Partial Monosomy Syndrome C0265451
congenital
1p35 2 Microdeletion Syndrome
congenital
Same/different system
Category
13q Partial Monosomy Syndrome C0265451
genetic
1p35 2 Microdeletion Syndrome
rare-disease
Different category
Bottom line
13q-partial-monosomy-syndrome-C0265451 and 1p35-2-microdeletion-syndrome-C5679992 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 13q Partial Monosomy Syndrome C0265451 | 1p35 2 Microdeletion Syndrome | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as a possible feature, but severity and pattern vary. | Not established from the supplied source data. | Low |
| Growth concern | Growth concerns are mentioned, without defined measurements. | Growth effects are not established here. | Low |
| Physical features | Various physical features may occur; none are definitive. | Characteristic features are not established from supplied data. | Low |
When to favor each condition
Choose 13q Partial Monosomy Syndrome C0265451 when
Genetic testing shows partial loss of chromosome 13 material
The chromosomal finding supports this diagnosis over a 1p finding.
High
Congenital developmental and growth concerns need a unifying explanation
These concerns are described for 13q partial monosomy, but are not specific.
Low
Counseling focuses on supportive care for individual challenges
Supportive, individualized care is the stated management approach.
Moderate
Choose 1p35 2 Microdeletion Syndrome when
Testing identifies a microdeletion at 1p35.2
The locus, not clinical appearance alone, distinguishes this condition.
High
Phenotype is uncertain or sparsely documented
Absence of supplied features should not exclude a confirmed chromosomal result.
Moderate
Family counseling requires condition-specific evidence
Clinicians should avoid extrapolating 13q features to this syndrome.
High
How key tests differ
| Test | 13q Partial Monosomy Syndrome C0265451 | 1p35 2 Microdeletion Syndrome | Interpretation |
|---|---|---|---|
| Karyotype | May detect a visible partial deletion of chromosome 13. | A small 1p35.2 deletion may not be visible. | A normal karyotype does not exclude a microdeletion. |
| Chromosomal microarray | Can localize and size deleted 13q material. | Can detect a copy-number loss at 1p35.2. | The genomic coordinates distinguish the conditions. |
| Clinical examination | May show variable developmental, growth, or physical findings. | Expected findings are not established here. | Examination supports care but does not replace genetic confirmation. |
Prognosis comparison
13q Partial Monosomy Syndrome C0265451
- Outcome
- Long-term outcome is variable and not quantified here.
- Factors
- Deleted region, associated findings, and available support may influence needs.
1p35 2 Microdeletion Syndrome
- Outcome
- Prognosis is not established from the supplied data.
- Factors
- Deletion size, genes involved, and individual findings require specialist interpretation.
Time frame: Lifelong, with needs that may change over time.
No mortality or prevalence comparison is established.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental challenges | Possible and individually variable. Not established from supplied data. Do not assume equivalent severity or needs. |
| Growth problems | Mentioned as a possible concern. Not established here. Growth assessment should be individualized. |
| Associated congenital anomalies | Various physical features may occur. Specific anomalies are not established here. Screening should follow clinician judgment and confirmed genetics. |
Patient education highlights
- HighDiagnosis
A chromosomal test result is not the same as predicting every symptom.
- HighEvidence limits
Features of 1p35.2 microdeletion are not established in the supplied material.
- MediumCare
Management is supportive and tailored; no dose or standard treatment is established here.